ROBOTIC GASTRIC BYPASS: THE FUTURE OF BARIATRIC SURGERY


Objective:

Compare robotic versus laparoscopic roux-en-Y gastric bypass (RYGB) for the treatment of morbid obesity in a community hospital.

Introduction:

Since receiving Food and Drug Administration approval in 2000, surgery utilizing a robot (da Vinci® Surgical System) has been successfully performed in numerous procedures including RYGB.
In addition, there are limited studies with relatively small sample sizes that have compared robotic vs. laparoscopic RYGB in the literature.

Methods:

Through a retrospective analysis of a prospectively collected database, we compared outcomes and complication rates of robotic vs. laparoscopic RYGB in the treatment of morbid obesity.
Outcomes data included weight loss, operative times, and hospital length of stay. All complications encountered by both groups were reported.

Results:

Eightypatients who underwent robotic RYGB were compared to 80 patients who received laparoscopic RYGB. Rate of weight loss and reduction in body mass index (BMI) over time were similar in both groups. There were no mortalities in either group.
Hospital length of stay and operative times were similar in both groups, but there was a trend towards a shorter length of stay with robotic RYGB.

Comments

Popular posts from this blog

Best Clinic to get Coronary Artery Disease Treatment in Waco, TX

Top Reasons to Use an HTML Gmail Signature Generator for Your Business

Step-by-Step Guide to Creating a Professional Email Signature with a Generator